Your account is not claimed yet. You can sign up with ORCID to claim your account.

Beihua Kong

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Journal of gynecologic oncology

Cell death & disease

Cancer medicine

Nature communications

Shandong University School of Medicine

Shandong University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shandong University School of Medicine

China

Vice Dean

Education History

Shandong University School of Medicine Sep 1o 1985 - Jul 1o 1990

China

PHD :: OB/GYN

Publications

Ran Chu, Penglin Liu, Jingying Chen, Xiaodong Cheng, Kezhen Li, Yanci Che, Jianliu Wang, Li Li, Xi Zhang, Shu Yao, Li Song, Ying Zhao, Changzhen Huang, Ying Xue, Xiyu Pan, Junting Li, Zhongshao Chen, Jie Jiang, Beihua Kong, Kun Song
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study. Journal of gynecologic oncology 34 (2) (2023)
Ran Chu, Penglin Liu, Jingying Chen, Xiaodong Cheng, Kezhen Li, Yanci Che, Jianliu Wang, Li Li, Xi Zhang, Shu Yao, Li Song, Ying Zhao, Changzhen Huang, Ying Xue, Xiyu Pan, Junting Li, Zhongshao Chen, Jie Jiang, Beihua Kong, Kun Song
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study. Journal of gynecologic oncology 34 (2) (2023)
Shourong Wang, Yao Liu, Huimin Xiao, Zhongshao Chen, Xiaohang Yang, Jingjing Yin, Yingwei Li, Cunzhong Yuan, Shi Yan, Gang Chen, Qinglei Gao, Beihua Kong, Chaoyang Sun, Kun Song
Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer. Cell death & disease 14 (11) (2023)
Ran Chu, Penglin Liu, Jingying Chen, Xiaodong Cheng, Kezhen Li, Yanci Che, Jianliu Wang, Li Li, Xi Zhang, Shu Yao, Li Song, Ying Zhao, Changzhen Huang, Ying Xue, Xiyu Pan, Junting Li, Zhongshao Chen, Jie Jiang, Beihua Kong, Kun Song
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study. Journal of gynecologic oncology 34 (2) (2023)
Zixiang Wang, Shourong Wang, Junchao Qin, Xiyu Zhang, Gang Lu, Hongbin Liu, Haiyang Guo, Ligang Wu, Victoria O Shender, Changshun Shao, Beihua Kong, Zhaojian Liu
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12. Nature communications 13 (1) (2022)
Shourong Wang, Zixiang Wang, Jieyin Li, Junchao Qin, Jianping Song, Yingwei Li, Ling Zhao, Xiyu Zhang, Haiyang Guo, Changshun Shao, Beihua Kong, Zhaojian Liu
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2. Cell death & disease 12 (4) (2021)
Ying Xu, Qing Zhang, Chunying Miao, Samina Dongol, Yinuo Li, Chenjuan Jin, Ruifeng Dong, Yingwei Li, Xingsheng Yang, Beihua Kong
CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression. Cancer medicine 8 (1) (2018)

Beihua Kong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Beihua Kong